Type 2 diabetes mellitus (T2DM) is a complicated, persistent, chronic disease. Obestatin is an anorexigenic gut hormone associated with atherosclerosis, increased insulin resistance and metabolic syndrome. This study aimed to examine serum obestatin levels in Egyptian patients with T2DM in addition to exploring their associations with diabetic microvascular complications.
(2023). Assessment Of Serum Obestatin In Patients with Type 2 Diabetes Mellitus in Correlation with Diabetic Microvascular Complications. Egyptian Society of Diabetes and Lipidology Journal, 3(1), -. doi: 10.21608/esdlj.2023.456147
MLA
. "Assessment Of Serum Obestatin In Patients with Type 2 Diabetes Mellitus in Correlation with Diabetic Microvascular Complications", Egyptian Society of Diabetes and Lipidology Journal, 3, 1, 2023, -. doi: 10.21608/esdlj.2023.456147
HARVARD
(2023). 'Assessment Of Serum Obestatin In Patients with Type 2 Diabetes Mellitus in Correlation with Diabetic Microvascular Complications', Egyptian Society of Diabetes and Lipidology Journal, 3(1), pp. -. doi: 10.21608/esdlj.2023.456147
VANCOUVER
Assessment Of Serum Obestatin In Patients with Type 2 Diabetes Mellitus in Correlation with Diabetic Microvascular Complications. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(1): -. doi: 10.21608/esdlj.2023.456147
)
